Download "A Broker’s Guide to Pharmacy Coalitions," for the expertise and insights you need to make strategic choices that enhance value and improve outcomes for your clients.

Brokers, TPAs and Groups: Selecting the right pharmacy coalition is a critical decision that can significantly impact your organization's pharmacy benefits strategy. Not all coalitions are created equal, and understanding what to look for can make the difference between a beneficial partnership and a missed opportunity.

Brokers frequently cringe at the thought of moving their groups to a different PBM because of the potential disruption it can cause. But it doesn’t have to be this way. Some coalitions today deliver 5-star customer service and comprehensive implementation support, making the transition smooth and hassle-free for everyone involved. While pricing and contract terms are crucial, the service provided by a pharmacy coalition can make or break your PBM implementation.

CoeoRx, a pharmacy benefit navigator working to help lower pharmacy benefit costs for self-funded employer groups, has announced the hiring of Kiley Ward as president and Cheri Rambo as executive vice president of business development.

As a result of pharmacy benefit complexity, the rising cost of prescription drugs and underperforming contracts, our TPA client searched for a partner to help them create and manage a complete pharmacy division that offered year-round support and powerful savings to their employer-group clients.

See how an independent TPA leveraged CoeoRx to reprice and optimize its pharmacy benefit contract to save $5.6M for its clients.

Brian Shonat, Goodroot’s area vice president of business development, recently joined Spencer Smith on the Self-Funded with Spencer podcast to talk CoeoRx, PBM contracts, specialty drugs and more. Below are some of the highlights of what Brian had to say during the hour-long chat.